Showing results (381-390 of 498) with videos related to

Sort By:
Pageof 50
Journal of the National Cancer Institute|January 16, 1991
Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administrationG D Pennock, W S Dalton, W R Roeske, et al.
Blood|January 15, 1993
P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapyT M Grogan, C M Spier, S E Salmon, et al.
The Journal of Biological Chemistry|March 28, 2013
The Joubert syndrome-associated missense mutation (V443D) in the Abelson-helper integration site 1 (AHI1) protein alters its localization and protein-protein interactionsKarina Tuz, Yi-Chun Hsiao, Oscar Juárez, et al.
The Journal of Experimental Medicine|November 23, 2006
Identification of a radio-resistant and cycling dermal dendritic cell population in mice and menMilena Bogunovic, Florent Ginhoux, Amy Wagers, et al.
Cogent Medicine|June 7, 2017
A longitudinal population study of the impact of cataract extraction on sleep qualityYanjun Chen, David M Nondahl, Carla R Schubert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Breast tissue accumulation of retinamides in a randomized short-term study of fenretinideAnita L Sabichi, Manual R Modiano, J Jack Lee, et al.
Blood|September 16, 2010
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181aTint Lwin, Jianhong Lin, Yong Sung Choi, et al.
Biochemical Pharmacology|May 5, 2000
pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell linesR Martínez-Zaguilán, N Raghunand, R M Lynch, et al.
Leukemia|March 30, 2013
Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicityX Zhao, T Lwin, X Zhang, et al.
JMIR Research Protocols|March 22, 2017
Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate FeasibilityBin Li, Steven A Eschrich, Anders Berglund, et al.
Pageof 50